Published in Nat Immunol on April 01, 2001
Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med (2007) 11.82
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol (2009) 8.65
The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol (2008) 6.56
Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A (2002) 6.19
The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J Exp Med (2008) 6.07
Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci U S A (2005) 5.96
Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature (2007) 5.81
Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med (2007) 5.52
Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A (2006) 5.50
In vivo instruction of suppressor commitment in naive T cells. J Exp Med (2004) 5.47
Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med (2003) 5.23
Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med (2004) 5.08
Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med (2003) 4.96
Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol (2009) 4.90
Stability of the regulatory T cell lineage in vivo. Science (2010) 4.89
T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med (2011) 4.71
Control of regulatory T cell lineage commitment and maintenance. Immunity (2009) 4.63
CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med (2003) 4.56
Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med (2003) 4.41
Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med (2003) 4.39
A two-step process for thymic regulatory T cell development. Immunity (2008) 4.29
In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci U S A (2003) 4.18
Checkpoint blockade in cancer immunotherapy. Adv Immunol (2006) 4.09
Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol (2009) 4.07
Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells. Immunity (2007) 3.98
A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity (2011) 3.76
Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity (2010) 3.69
Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol (2004) 3.58
Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity (2008) 3.56
The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol (2007) 3.51
Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J Exp Med (2001) 3.47
Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc Natl Acad Sci U S A (2002) 3.41
Certified professionals: CD4(+)CD25(+) suppressor T cells. J Exp Med (2001) 3.39
Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat Immunol (2009) 3.38
Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity (2007) 3.02
Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J Exp Med (2004) 2.92
CD4+ Tregs and immune control. J Clin Invest (2004) 2.85
Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature (2013) 2.75
A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest (2005) 2.71
Antigen-specific peripheral shaping of the natural regulatory T cell population. J Exp Med (2008) 2.68
Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines. Blood (2005) 2.60
Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med (2002) 2.60
Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family. Immunol Rev (2011) 2.54
Selection of regulatory T cells in the thymus. Nat Rev Immunol (2012) 2.51
Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med (2005) 2.42
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen. Cancer Cell (2005) 2.37
Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci U S A (2002) 2.35
Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2004) 2.34
Distinct contributions of Aire and antigen-presenting-cell subsets to the generation of self-tolerance in the thymus. Immunity (2014) 2.33
Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc Natl Acad Sci U S A (2008) 2.26
CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther (2004) 2.25
Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc Natl Acad Sci U S A (2008) 2.24
TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J Exp Med (2010) 2.20
Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A (2010) 2.19
TCR-dependent differentiation of thymic Foxp3+ cells is limited to small clonal sizes. J Exp Med (2009) 2.18
T cell regulation as a side effect of homeostasis and competition. J Exp Med (2003) 2.15
TCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets. J Exp Med (2007) 2.15
Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period. J Exp Med (2005) 2.12
A broad range of self-reactivity drives thymic regulatory T cell selection to limit responses to self. Immunity (2012) 2.10
Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc Natl Acad Sci U S A (2004) 2.09
Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity (2008) 2.09
How do regulatory T cells work? Scand J Immunol (2009) 2.02
Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol Rev (2009) 2.00
Selection of self-reactive T cells in the thymus. Annu Rev Immunol (2011) 1.98
Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity (2013) 1.96
Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut (2005) 1.95
Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci U S A (2005) 1.90
Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance. Nat Immunol (2010) 1.89
Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors. Neuro Oncol (2011) 1.89
Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node. J Exp Med (2005) 1.88
The timing of TCR alpha expression critically influences T cell development and selection. J Exp Med (2005) 1.85
Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol (2009) 1.84
Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology (2002) 1.81
How the TCR balances sensitivity and specificity for the recognition of self and pathogens. Nat Immunol (2012) 1.80
SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol Rev (2009) 1.78
CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol (2005) 1.76
Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. J Clin Invest (2004) 1.74
Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J Exp Med (2005) 1.67
The development and function of regulatory T cells. Cell Mol Life Sci (2009) 1.66
LAT-mediated signaling in CD4+CD25+ regulatory T cell development. J Exp Med (2005) 1.65
Imbalance of regulatory T cells in human autoimmune diseases. Immunology (2006) 1.64
CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J Exp Med (2003) 1.63
Natural regulatory T cells and persistent viral infection. J Virol (2007) 1.62
A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance. Nature (2015) 1.62
The transcriptional landscape of αβ T cell differentiation. Nat Immunol (2013) 1.61
Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome. J Immunol (2012) 1.61
Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat Immunol (2009) 1.61
Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Res Ther (2005) 1.60
Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers. PLoS One (2011) 1.60
Endogenous galectin-1 enforces class I-restricted TCR functional fate decisions in thymocytes. Blood (2008) 1.60
Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target. Immunology (2008) 1.59
Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J Exp Med (2002) 1.58
Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance. Immunity (2012) 1.57
Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infection. J Exp Med (2001) 1.57
Medullary thymic epithelial cell depletion leads to autoimmune hepatitis. J Clin Invest (2013) 1.57
GILT modulates CD4+ T-cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1. J Invest Dermatol (2011) 1.56
Quantitative impact of thymic selection on Foxp3+ and Foxp3- subsets of self-peptide/MHC class II-specific CD4+ T cells. Proc Natl Acad Sci U S A (2011) 1.54
Alteration of intra-pancreatic target-organ specificity by abrogation of Aire in NOD mice. J Clin Invest (2006) 1.52
Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes. Proc Natl Acad Sci U S A (2007) 1.51
The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell (1982) 12.44
Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (1994) 5.76
CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity (1997) 4.54
Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med (2001) 4.07
Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J Exp Med (2001) 3.47
The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. Virology (1986) 3.34
Availability of reduced N and carbohydrates for ear development of maize. Plant Physiol (1981) 3.03
Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science (1998) 2.76
Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies. J Virol (1986) 2.52
Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J Exp Med (1991) 2.51
Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype. Nucleic Acids Res (1983) 2.41
Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science (1990) 2.25
Influenza virus RNA is synthesized at fixed sites in the nucleus. Nature (1982) 2.18
Structure of the host-derived sequences present at the 5' ends of influenza virus mRNA. Nucleic Acids Res (1980) 2.14
A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity (1994) 2.09
Host cell-mediated selection of a mutant influenza A virus that has lost a complex oligosaccharide from the tip of the hemagglutinin. Proc Natl Acad Sci U S A (1986) 1.84
B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes (1997) 1.75
Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. Proc Natl Acad Sci U S A (1989) 1.71
I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol (1999) 1.56
Antigen presenting function of class II MHC expressing pancreatic beta cells. Nature (1988) 1.56
A new Igk-V gene family in the mouse. Immunogenetics (1990) 1.43
Structural and functional implications of a restricted antibody response to a defined antigenic region on the influenza virus hemagglutinin. EMBO J (1986) 1.40
High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest (1995) 1.33
Anergy and suppression regulate CD4(+) T cell responses to a self peptide. Eur J Immunol (2000) 1.32
Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable. J Clin Pharmacol (2000) 1.29
Living-related donors with bilateral multiple renal arteries. A twenty-year experience. Transplantation (1989) 1.28
Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice. J Virol (1991) 1.24
Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J Exp Med (1995) 1.18
New procedure for the production of influenza virus-specific double-stranded DNA's. Nucleic Acids Res (1979) 1.16
Spontaneous diabetes in rats: destruction of islets is prevented by immunological tolerance. Science (1981) 1.16
Glutamine enhancement of structure and function in transplanted small intestine in the rat. JPEN J Parenter Enteral Nutr (1993) 1.15
A set of closely related antibodies dominates the primary antibody response to the antigenic site CB of the A/PR/8/34 influenza virus hemagglutinin. J Immunol (1990) 1.15
Analytical and functional studies on the T cells of untreated and immunologically tolerant diabetes-prone BB rats. J Immunol (1983) 1.15
Calcification in the dental pulp. Oral Surg Oral Med Oral Pathol (1968) 1.11
Spontaneous diabetes in BB rats: evidence for a T cell dependent immune response defect. Diabetologia (1982) 1.10
Treatment of portal vein thrombosis after liver transplantation with percutaneous thrombolysis and stent placement. J Vasc Interv Radiol (1994) 1.10
Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. Science (1992) 1.10
Expansion of natural (NK1+) T cells that express alpha beta T cell receptors in transporters associated with antigen presentation-1 null and thymus leukemia antigen positive mice. J Exp Med (1996) 1.07
Structure-function relationships among highly diverse T cells that recognize a determinant from influenza virus hemagglutinin. J Exp Med (1990) 1.06
Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes (1999) 1.05
A B cell population that dominates the primary response to influenza virus hemagglutinin does not participate in the memory response. Eur J Immunol (1991) 1.04
NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G. Leukemia (2008) 1.04
Active signaling by Neu in transgenic mice. Oncogene (1998) 1.03
Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice. J Immunol (2000) 1.03
Percutaneous thrombolysis and stent placement for the treatment of portal vein thrombosis after liver transplantation: long-term follow-up. Transplantation (1998) 1.03
Major histocompatibility complex restriction and transplantation immunity. A possible solution to the allograft problem. Transplantation (1984) 1.02
Bar workers' health and environmental tobacco smoke exposure (BHETSE): symptomatic improvement in bar staff following smoke-free legislation in Scotland. Occup Environ Med (2009) 1.02
Disseminated mycobacterium kansasii infection presenting as cellulitis in a recipient of a renal homograft. Am Rev Respir Dis (1975) 1.01
Evidence for major histocompatibility complex restriction in transplantation immunity. Proc Natl Acad Sci U S A (1982) 1.01
Validation of methodologies for quantifying isolated human islets: an Islet Cell Resources study. Clin Transplant (2009) 1.00
Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice. J Immunol (2001) 1.00
Autoimmunity and type I (insulin-dependent) diabetes mellitus. Transplantation (1983) 1.00
Antibodies that are specific for a single amino acid interchange in a protein epitope use structurally distinct variable regions. J Exp Med (1991) 0.99
Linkage analysis of fifty-seven microsatellite loci to bipolar disorder. Neuropsychopharmacology (1993) 0.98
Hemagglutinin polymorphism as the basis for low- and high-yield phenotypes of swine influenza virus. Proc Natl Acad Sci U S A (1988) 0.97
Diffusive motion of C60 on a graphene sheet. Phys Rev E Stat Nonlin Soft Matter Phys (2010) 0.96
The ATP/DNA ratio is a better indicator of islet cell viability than the ADP/ATP ratio. Transplant Proc (2008) 0.96
Immunologic effects of arginine supplementation in tumor-bearing and non-tumor-bearing hosts. Ann Surg (1990) 0.96
Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo. Transplantation (1991) 0.95
Some New Aspects of the in Vivo Assay for Nitrate Reductase in Wheat (Triticum aestivum L.) Leaves: I. REEVALUATION OF NITRATE POOL SIZES. Plant Physiol (1980) 0.93
Induction of donor-specific tolerance to rat cardiac allografts by intrathymic inoculation of bone marrow. Surgery (1992) 0.93
Strong-coupling electrostatics in the presence of dielectric inhomogeneities. Phys Rev Lett (2008) 0.93
Low avidity recognition of a class II-restricted neo-self peptide by virus-specific T cells. Int Immunol (1995) 0.92
Successful islet transplantation in spontaneous diabetes. Surgery (1979) 0.92
A major T cell determinant from the influenza virus hemagglutinin (HA) can be a cryptic self peptide in HA transgenic mice. Int Immunol (1997) 0.92
A PCR-based assay for the wild-type dystrophin gene transferred into the mdx mouse. Muscle Nerve (1992) 0.91
Influence of organ culture on the survival of major histocompatibility complex-compatible and incompatible parathyroid allografts in rats. Transplantation (1981) 0.90
Thermolabile H-2Kb molecules expressed by transporter associated with antigen processing-deficient RMA-S cells are occupied by low-affinity peptides. J Immunol (1999) 0.90
Virus-induced maturation and activation of autoreactive memory B cells. J Exp Med (2000) 0.90
Weak- and strong-coupling electrostatic interactions between asymmetrically charged planar surfaces. Phys Rev E Stat Nonlin Soft Matter Phys (2008) 0.89
Survival of MHC-deficient mouse heterotopic cardiac allografts. Transplantation (1995) 0.89
Synthesis and evaluation of fluorine-18 labeled glyburide analogs as beta-cell imaging agents. Nucl Med Biol (2004) 0.89
The effect of islet cell culture in vitro at 24 degrees C on graft survival and MHC antigen expression. Transplantation (1990) 0.89
Cutting edge: alloimmune responses against major and minor histocompatibility antigens: distinct division kinetics and requirement for CD28 costimulation. J Immunol (1999) 0.89
Graded deletion and virus-induced activation of autoreactive CD4+ T cells. J Immunol (2000) 0.89
Simultaneous thoracic and abdominal transplantation: can we justify two organs for one recipient? Am J Transplant (2013) 0.89
A direct method for the calculation of alloreactive CD4+ T cell precursor frequency. Transplantation (1999) 0.88
Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients. Am J Transplant (2010) 0.88
Immunologic problems in islet transplantation. Diabetes (1980) 0.88
Arginine, protein malnutrition, and cancer. J Surg Res (1988) 0.88
Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients. Am J Clin Pathol (2000) 0.87
Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors. Cell Immunol (1999) 0.87
Influence of culturing on the survival of major histocompatibility complex-compatible and -incompatible thyroid grafts in rats. J Exp Med (1983) 0.87
Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction. Leukemia (2012) 0.87
Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trial. Arch Surg (1988) 0.87
A recent decrease in the time to development of monomorphous and polymorphous posttransplant lymphoproliferative disorder. Transplantation (1992) 0.87
Preliminary report on effect of topical applications of titanium tetrafluoride on dental caries. J Dent Res (1976) 0.85
Gamma interferon induces novel expression of Ia antigens by rat pancreatic islet endocrine cells. Pancreas (1987) 0.85
Genetic basis for T cell recognition of a major histocompatibility complex class II-restricted neo-self peptide. J Exp Med (1995) 0.85
Influence of islet and bone marrow transplantation on the diabetes and immunodeficiency of BB rats. Metabolism (1983) 0.85
Development of anti-human leukocyte antigen class 1 antibodies following allogeneic islet cell transplantation. Transplant Proc (2005) 0.85
Regulatory T-cell counter-regulation by innate immunity is a barrier to transplantation tolerance. Am J Transplant (2009) 0.85
Treatment of lymphocele in renal allograft recipients. Arch Surg (1985) 0.85
Results of 100 consecutive femoropopliteal vein grafts for limb salvage. Ann Surg (1978) 0.84
A new mouse T-cell receptor alpha chain variable region family. Immunogenetics (1991) 0.84
Antigenic variation in influenza virus. Biochem Soc Trans (1983) 0.84
The origin of anti-nuclear antibodies in bcl-2 transgenic mice. Int Immunol (2000) 0.84